VEGFA and amyotrophic lateral sclerosis: Although there is evidence for and against the role of VEGF in ALS etiopathogenesis, the literature has widespread interest in developing VEGF-based therapies for motoneuron degenerative disorders, raising new hope for the treatment of ALS and other neurodegenerative diseases.